Journey Medical CorporationDERMNASDAQ
Loading
Cost of Revenue Over TimeContracting
Percentile Rank64
3Y CAGR-15.2%
5Y CAGR+5.2%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

3Y CAGR
-15.2%/yr
vs +126.2%/yr prior
5Y CAGR
+5.2%/yr
Recent deceleration
Acceleration
-141.3pp
Decelerating
Percentile
P64
Within normal range
vs 5Y Ago
1.3x
Solid growth
Streak
4 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$18.79M-10.0%
2024$20.88M-21.7%
2023$26.66M-13.4%
2022$30.77M-4.1%
2021$32.08M+119.8%
2020$14.59M+38.6%
2019$10.53M+795.6%
2018$1.18M-
2017$0.00-
2016$0.00-